间质性肺疾病相关肺动脉高压的诊疗实践
间质性肺疾病(ILD)相关肺动脉高压(PH)在纤维性ILD患者中常见,诊断和管理困难。本文以纵向病例讨论形式,梳理诊断流程中的要点与陷阱,并提供基于证据的诊疗框架。
要点
- ILD-PH患者常合并多种共病,需仔细鉴别PH的病因。
- 支持PH特异性药物治疗ILD-PH的证据有限。
- 诊断评估需注意要点与陷阱,遵循结构化框架。
核心结论
- ILD相关PH的诊断和管理具有独特挑战,需基于病例的实践框架进行准确诊断和管理。
研究设计与样本
- 本文为「How I Do It」栏目,采用纵向病例讨论形式,未报告样本量。
主要发现
- 纤维性ILD患者中PH常见,但支持PH特异性药物治疗的证据有限。
临床怎么用
- 临床中应关注ILD-PH诊断流程的要点与陷阱,采用基于证据的框架进行管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interstitial lung disease (ILD) is a term encompassing a wide array of pulmonary conditions characterized by inflammation and fibrosis of the pulmonary parenchyma. Pulmonary hypertension (PH) is frequently encountered in patients with fibrotic ILDs and poses unique difficulties for both diagnosis and management. Patients with ILD-associated pulmonary hypertension (ILD-PH) are complex, often ailing and presenting with multiple comorbidities whose individual contributions to the underlying PH can be challenging to disentangle. Evidence supporting treatment with PH-specific medications in ILD-PH is limited. This edition of "How I Do It" presents a longitudinal case-based discussion of ILD-PH to address these challenges, highlight pearls and pitfalls in the diagnostic workup of these patients, and provide a framework for the practical evidence-based approach to accurate diagnosis and management of these challenging cases.
引用
- Jose A, Sood N, Elwing JM, et al. Pulmonary Hypertension Associated With Interstitial Lung Diseases. Chest. 2025. PMID: 40939937. doi:10.1016/j.chest.2025.07.4107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。